Biorce

Biorce runs Aika, an AI platform trained on about one million clinical trials that helps pharmaceutical and biotech teams design regulator ready protocols and cut preparation timelines by up to half. The Barcelona based company closed a 52 million dollar Series A in February 2026 led by DST Global Partners, taking total funding past 60 million dollars.